Free database of papers and journals






Results 1 to 20 of 159 articles found
2021

Hydroxychloroquine with or without Azithromycin in Covid-19

New England Journal of Medicine (24.9 1209★★★), 384, 190-191.
2020

Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

New England Journal of Medicine (24.9 1209★★★), 383, 1087-1089.
2020

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

New England Journal of Medicine (24.9 1209★★★), 383, 2030-2040.
2020

Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence

New England Journal of Medicine (24.9 1209★★★), 383, 585-586.
2005

Hydroxychloroquine and Surfactant Protein C Deficiency

New England Journal of Medicine (24.9 1209★★★), 352, 207-208.
2020

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

New England Journal of Medicine (24.9 1209★★★), 383, 2041-2052.
2020

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

New England Journal of Medicine (24.9 1209★★★), 382, 2411-2418.
2020

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

New England Journal of Medicine (24.9 1209★★★), 383, 517-525.
2021

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19

New England Journal of Medicine (24.9 1209★★★), 384, 417-427.
1996

Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications

New England Journal of Medicine (24.9 1209★★★), 334, 1287-1291.
2011

Case 11-2011

New England Journal of Medicine (24.9 1209★★★), 364, 1450-1460.
2013

Case 39-2013

New England Journal of Medicine (24.9 1209★★★), 369, 2438-2449.
2020

Mild or Moderate Covid-19

New England Journal of Medicine (24.9 1209★★★), 383, 1757-1766.
2021

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

New England Journal of Medicine (24.9 1209★★★), 384, 497-511.
1967

Agranulocytosis and Hydroxychloroquine

New England Journal of Medicine (24.9 1209★★★), 277, 492-493.
2020

Drug Evaluation during the Covid-19 Pandemic

New England Journal of Medicine (24.9 1209★★★), 382, 2282-2284.
2020

Case 18-2020: A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction

New England Journal of Medicine (24.9 1209★★★), 382, 2354-2364.
2004

Therapeutic Strategies for Rheumatoid Arthritis

New England Journal of Medicine (24.9 1209★★★), 350, 2591-2602.
2016

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease

New England Journal of Medicine (24.9 1209★★★), 374, 1209-1220.
2007

A Stain in Time

New England Journal of Medicine (24.9 1209★★★), 356, 68-74.
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions